摘要
目的建立CHL3A4细胞系为某些遗传毒性化合物的代谢途径研究提供模型细胞系,并用于新合成化学物质的致突变性检测。方法应用RTPCR和DNA重组技术从人肝组织中克隆细胞色素P4503A4基因的cDNA至BluescriptM13载体上,经限制性内切酶图谱分析和克隆片段部分序列测定,证实为CYP3A4cDNA。然后构建真核细胞重组表达质粒pREP93A4,导入中国仓鼠CHL细胞。结果建立了CHL3A4转基因细胞系,双核细胞微核试验证明该细胞系能代谢活化黄曲霉毒素B1(AFB1)、杂色霉菌毒素(STC)、环磷酰胺(CPA)。结论所建CHL3A4细胞系确实能表达人细胞色素P4503A4,并能代谢活化AFB1、STC、CPA。
Objective To establish a model cell line CHL 3A4 to study metabolic pathways for some genotoxic chemicals. Methods Complimentary DNA (cDNA) of cloned cytochrome P450 3A4 gene in human liver tissue was transferred to Bluescript M13 vector with reverse transcription polymerase chain reaction (RT PCR) and DNA recombinant techniques. Restriction endonuclease map analysis and sequencing of partial cloned fragment proved that CYP3A4 cDNA was cloned into Bluescript M13 vector. Then, recombinant expression plasmid pREP9 3A4 was constructed in eukaryotic cell and transfected into Chinese hamster CHL cells. Results It was proved that a CHL 3A4 transgenic cell line was established, which could lead metabolic activation for aflatoxin B1 (AFB1), sterigmatocystin (STC) and cyclophosphamide (CPA). Conclusion The CHL 3A4 cell line established did express human cytochrome P450 3A4 and could lead metabolic activation for three genotoxic chemicals AFB1, STC and CPA.
出处
《中华预防医学杂志》
CAS
CSCD
北大核心
1998年第5期281-284,共4页
Chinese Journal of Preventive Medicine
基金
国家自然科学基金